UNICA IRIS Institutional Research Information System

DEL ZOMPO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 263.865
NA - Nord America 11.851
AS - Asia 1.632
SA - Sud America 18
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
Totale 277.398
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 260.973
US - Stati Uniti d'America 11.811
CN - Cina 1.138
UA - Ucraina 1.008
SE - Svezia 667
DE - Germania 380
GB - Regno Unito 318
SG - Singapore 289
FI - Finlandia 284
FR - Francia 91
IN - India 75
VN - Vietnam 64
CA - Canada 34
RU - Federazione Russa 34
BE - Belgio 31
NL - Olanda 16
BR - Brasile 14
KR - Corea 14
CZ - Repubblica Ceca 10
ES - Italia 10
EU - Europa 10
IE - Irlanda 10
JP - Giappone 10
IL - Israele 9
AU - Australia 8
HK - Hong Kong 8
IR - Iran 7
TR - Turchia 7
MU - Mauritius 6
GR - Grecia 5
RO - Romania 5
CH - Svizzera 4
EG - Egitto 4
MX - Messico 4
PL - Polonia 4
BG - Bulgaria 3
PT - Portogallo 3
QA - Qatar 3
AR - Argentina 2
HN - Honduras 2
HU - Ungheria 2
NG - Nigeria 2
NP - Nepal 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
DK - Danimarca 1
EC - Ecuador 1
ID - Indonesia 1
IQ - Iraq 1
IS - Islanda 1
KG - Kirghizistan 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
VE - Venezuela 1
Totale 277.398
Salva come PNG Salva come JPEG
Città #
Cagliari 255.823
Uta 4.530
Fairfield 1.669
Woodbridge 1.165
Chandler 1.012
Houston 868
Ashburn 839
Seattle 652
Wilmington 652
Boardman 642
Ann Arbor 640
Cambridge 532
Jacksonville 517
Nyköping 472
Dearborn 256
Nanjing 178
Beijing 155
Santa Clara 155
New York 150
Singapore 146
Boston 144
Shanghai 128
Helsinki 127
San Diego 90
Shenyang 69
Redwood City 66
Dong Ket 64
Nanchang 61
Hangzhou 56
Milan 53
Jiaxing 52
Mountain View 51
Norwalk 50
Verona 45
Hebei 44
Changsha 39
Guangzhou 36
London 35
Pune 35
Atlanta 34
Jinan 33
Tianjin 33
Brussels 31
Los Angeles 30
Orange 28
Toronto 25
Zhengzhou 23
Auburn Hills 21
Rome 21
Southend 21
Falls Church 20
Washington 20
Hefei 19
San Mateo 18
Ningbo 17
Sassari 17
Kunming 16
Saint Petersburg 16
Seoul 13
Redmond 12
Detroit 11
Taizhou 10
Brno 9
Olbia 9
Phoenix 9
Mumbai 8
Nürnberg 8
Shaoxing 8
Tappahannock 8
Dublin 7
Fuzhou 7
Paris 7
Shenzhen 7
Wuhan 7
Ardabil 6
Augusta 6
Azor 6
Borås 6
Chicago 6
Frankfurt am Main 6
Indiana 6
Jinhua 6
Leawood 6
Monmouth Junction 6
New Bedfont 6
Rockville 6
San Francisco 6
Serramanna 6
Brisbane 5
Cedar Knolls 5
Edinburgh 5
Suni 5
Wandsworth 5
Acton 4
Baoding 4
Baotou 4
Bologna 4
Boydton 4
Cairo 4
Chiswick 4
Totale 273.018
Salva come PNG Salva come JPEG
Nome #
Carbamazepine augmentation in lithium refractory bipolar patients: a prospective study on long-term prophylactic effectiveness 12.023
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.194
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 4.106
Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study 3.623
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 3.520
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study 3.519
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 3.393
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.344
Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study 3.343
Continuation versus discontinuation of lithium during pregnancy: a retrospective case series 3.135
An observational study of 110 elderly lithium-treated patients followed up for 6 years with particular reference to renal function 3.020
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 2.971
Dopaminergic and serotonergic genes in bipolar disorder: A case control study in a Sardinian population 2.953
Analysis of the influence of microRNAs in lithium response in bipolar disorder 2.938
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 2.903
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 2.888
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 2.875
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study 2.814
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.757
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder 2.748
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study 2.744
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.724
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.665
Involvement of core clock genes in lithium response 2.660
Differential effect of lithium on spermidine/spermine N1-acetiltransferase expression in suicidal behaviour 2.648
Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder. A genome-wide association study 2.596
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.563
Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients 2.562
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.553
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.536
Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder 2.532
null 2.498
Online information seeking by patients with bipolar disorder: results from an international multisite survey 2.493
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database. 2.475
Genome-scan for bipolar disorder with sib-pair families in the Sardinian population: a new susceptibility locus on chromosome 1p22-p21? 2.370
High leptin levels are associated with migraine with aura 2.354
Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder 2.340
Prediction of Lithium Response using Clinical Data 2.339
Novel integrative genomic tool for interrogating lithium response in bipolar disorder 2.330
Pharmacogenomics of bipolar disorder 2.268
Association study in three different populations between the GPR88 gene and major psychoses 2.249
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.241
Fifteen-year follow-up of thyroid function in lithium patients 2.230
Internet use by patients with bipolar disorder: Results from an international multisite survey 2.202
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 2.167
Cellular models to study bipolar disorder: a systematic review 2.091
Age at onset in bipolar disorder: investigation of the role of TaqIA polymorphism of DRD2 gene in a Sardinian sample 2.050
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 2.029
Lithium-induced differential expression of SAT1 in suicide completers and controls is not correlated with polymorphisms in the promoter region of the gene 1.993
Solar insolation in springtime influences age of onset of bipolar I disorder 1.992
557. Pharmacogenetic Association of Lithium Treatment Response with Bcl2 Polymorphism in Bipolar Disorder 1.980
null 1.980
Convergent genetic and expression data implicate immunity in Alzheimer's disease 1.931
Association between solar insolation and a history of suicide attempts in bipolar I disorder 1.926
Long term lithium treatment and survival from external causes including suicide 1.878
Assessment of response to lithium maintenance treatment in bipolar disorder: A Consortium on Lithium Genetics (ConLiGen) report 1.849
Internet use by older adults with bipolar disorder: international survey results 1.845
null 1.842
Characterisation of age and polarity at onset in bipolar disorder 1.827
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.780
Clinical factors associated with lithium treatment response in bipolar disorder patients from India 1.769
A genetic risk score is differentially associated with migraine with and without aura 1.739
The international consortium on lithium genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment 1.691
No evidence of association between dopamine D3 receptor gene and bipolar affective disorder 1.669
Value of thyroid echography in the long-term follow-up of lithium-treated patients 1.649
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.581
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 1.573
A retrospective case series of bipolar patients with adjunctive carbamazepine in long-term lithium treatment: evaluation of the effectiveness 1.555
Admixture analysis of age at onset in bipolar disorder 1.545
null 1.525
Insulin-like growth factor 1 differentially affects lithium sensitivity of lymphoblastoid cell lines from lithium responder and non-responder bipolar disorder patients 1.520
Haplotype association study between DRD1 gene and bipolar type I affective disorder in two samples from Canada and Sardinia 1.515
Farmaci per il trattamento delle cefalee primitive e per il controllo del vomito 1.509
Clozapine toxicity due to a multiple drug interaction: a case report 1.486
Prediction of lithium response using genomic data 1.481
null 1.449
null 1.424
null 1.414
Influence of light exposure during early life on the age of onset of bipolar disorder 1.401
null 1.334
Genetic linkage and association studies in affective disorders 1.328
A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample 1.317
Relationship between sunlight and the age of onset of bipolar disorder: an international multisite study 1.302
Age at Onset in Sardinian Bipolar I Patients: Evidence for Three Subgroups 1.234
Influence of birth cohort on age of onset cluster analysis in bipolar I disorder 1.201
null 1.161
Six-year follow-up of thyroid function during lithium treatment 1.156
Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patiens 1.150
null 1.146
Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients 1.146
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.130
A48G polymorphism in the D1 receptor genes associated with bipolar I disorder 1.123
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. 1.112
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 1.105
Evaluation of lithium response in episodic cluster headache: a retrospective case series 1.102
null 1.100
Thyroid abnormalities during lithium treatment 1.062
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 1.047
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.045
Catechol-O-methyltransferase Val(158)Met polymorphism in schizophrenia: associations with cognitive and motor impairment 982
Totale 217.177
Salva come PNG Salva come JPEG
Categoria #
all - tutte 334.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 334.698
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036.643 0 0 0 0 14.511 10.023 5.800 1.512 1.111 881 951 1.854
2020/202161.611 1.922 2.341 2.420 15.000 11.928 7.632 5.431 4.546 1.576 3.262 3.433 2.120
2021/202214.194 1.828 1.069 802 973 1.113 903 1.028 822 1.259 1.390 1.580 1.427
2022/202320.690 1.579 2.881 2.643 1.777 1.670 2.293 887 1.674 1.569 1.324 1.592 801
2023/202420.950 1.043 1.047 885 1.700 1.899 3.489 2.967 1.300 908 1.333 2.379 2.000
2024/202566.292 26.215 24.066 9.999 4.266 1.746 0 0 0 0 0 0 0
Totale 277.937